A global healthcare investment firm wanted to perform a commercial due diligence (CDD) prior to investment in a company producing a novel handheld diagnostic.
Key takeaways from DeciBio’s presentation to the client team included:
Product Performance and Specification Mapping
Addressable Market Sizing
Novel Technology Commercialization